Navigation Links
Nutraceutical Reports Fiscal 2009 Q2 Results
Date:4/30/2009

PARK CITY, Utah, April 30 /PRNewswire-FirstCall/ -- Nutraceutical International Corporation (Nasdaq: NUTR) today reported results for the fiscal 2009 second quarter ended March 31, 2009. Net sales for the fiscal 2009 second quarter were $42.0 million compared to $44.4 million for the same quarter of fiscal 2008.

Primarily as a result of the ongoing U.S. and global economic recession and the related turmoil in the equity markets, there has been a significant and prolonged decrease in the Company's stock price and related market capitalization over the past six months. The ongoing economic recession also has negatively impacted the Company during this period, both domestically and internationally. Based on these factors, the Company determined that an interim goodwill impairment analysis was necessary and performed this goodwill impairment analysis on each of its reporting units during the second quarter of fiscal 2009 in accordance with Statement of Financial Accounting Standards No. 142, Goodwill and Other Intangible Assets. Based on the results of this goodwill impairment analysis, a non-cash goodwill impairment charge of $37.5 million ($27.3 million after tax, or $2.51 per diluted share) was recorded during the second quarter of fiscal 2009.

This non-cash goodwill impairment charge resulted in a net loss of $(23.4) million, or $(2.15) per diluted share, for the second quarter of fiscal 2009, compared to net income of $4.4 million, or $0.39 per diluted share, for the same quarter of fiscal 2008. Excluding the above non-cash impairment charge, net income for the second quarter of fiscal 2009 would have been $3.9 million, or $0.36 per diluted share.

Net sales for the six months ended March 31, 2009 were $81.6 million compared to $85.5 million for the same period in fiscal 2008. The non-cash goodwil
'/>"/>

SOURCE Nutraceutical International Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Physician Develops Resveratrol Evidence-Based Nutraceutical for Heart Health
2. Nutraceutical Reports Fiscal 2009 Q1 Results
3. Valensa International and Parry Nutraceuticals Join Forces in the Global Natural Products Marketplace
4. Nutraceutical Reports 2008 Fiscal Year End Results
5. Valensa and Parry Nutraceuticals Introduce Organic SpiruZan(TM) Spirulina/Astaxanthin Complex as Lifestyle Support for a Fast-Paced World
6. Nutraceutical to Present at Canaccord Adams Healthy Living Conference
7. Nutraceuticals could prevent diabetes
8. Nutraceutical Reports Q3 Results
9. Dermatologists In Denial: Controversial New Chocolate Nutraceutical Claims to be Good for Your Skin
10. Photos: For the First Time Researchers Show Reversal of an Aging Marker in the Human Retina Correlated with Visual Improvement Using a Nutraceutical Matrix (Longevinex(R))
11. Berkeley Premium Nutraceuticals Pushes Forward
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Roper Industries Completes the Acquisition of Verathon, Inc. 2Roper Industries Completes the Acquisition of Verathon, Inc. 3Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 2Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 3Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 4Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 5Reportlinker Adds South Korean Market for Dental Implants and Final Abutments 2009 6Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 2Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 3Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 4Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 5Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 6Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 7Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 8Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 9Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 10Reportlinker Adds Ambulatory and Bathroom Aids - A Worldwide Market Review 11Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barc 4921 1Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barc 4921 2Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barc 4921 3Raptor Pharmaceuticals Schedules 2009 Annual Meeting of Stockholders 13738 1Raptor Pharmaceuticals Schedules 2009 Annual Meeting of Stockholders 13738 2Raptor Pharmaceuticals Schedules 2009 Annual Meeting of Stockholders 13738 3VNA of Hanover 26 Spring Grove Selects Cardiocom Telehealth Technology as Its New Telehealth Provider 55693 1VNA of Hanover 26 Spring Grove Selects Cardiocom Telehealth Technology as Its New Telehealth Provider 55693 2